#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4532	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2806	478.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	2152	2152	T	618	T	552	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4532	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2806	478.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1886	1886	C	606	C,G	521,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7188	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4053	531.1	0	.	n	.	0	A9G	SNP	9	9	A	567	567	G	757	G	639	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7188	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4053	531.1	0	.	n	.	0	T695C	SNP	695	695	T	1253	1253	C	520	C,T	432,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7188	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4053	531.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2529	2529	C	719	C,T,G	620,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7188	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4053	531.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3155	3155	T	633	T	536	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7188	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4053	531.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2603	2603	A	720	A,G,T	611,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	712	folP	855	855	99.77	folP.l6.c4.ctg.1	1900	112.4	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	1227	1229	AGC	168;168;168	A;G;C	144;149;148	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1452	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3730	116.3	0	.	p	.	0	T243I	NONSYN	727	729	ACA	1172	1174	ATA	122;123;123	A,G;T;A	103,1;107;109	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1452	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3730	116.3	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1193	1195	ATA	124;125;126	A;T,A;A	109;106,1;110	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1452	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3730	116.3	1	SNP	p	S91F	0	.	.	271	273	TCC	716	718	TCC	144;144;145	T;C;C	121;121;125	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1452	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3730	116.3	1	SNP	p	D95N	0	.	.	283	285	GAC	728	730	GAC	138;140;140	G;A;C	123;124;121	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1452	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3730	116.3	1	SNP	p	D95G	0	.	.	283	285	GAC	728	730	GAC	138;140;140	G;A;C	123;124;121	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	531	694	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	1851	112.5	0	.	p	.	0	P191fs	FSHIFT	571	571	C	1148	1148	C	200	C	166	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	531	694	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	1851	112.5	1	SNP	p	G45D	0	.	.	133	135	GGC	709	711	GGC	188;187;187	G,T;G,C;C,T	159,1;157,1;160,1	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	448	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1400	95.8	0	.	n	.	0	.206T	INS	206	206	T	788	788	T	171	T	152	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1456	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3334	130.9	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1790	1792	GCC	151;151;152	G;C,T;C	126;124,1;124	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1456	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3334	130.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1832	1834	GCA	152;152;152	G,A;C,T;A,G	130,1;127,1;124,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1456	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3334	130.9	1	SNP	p	D86N	0	.	.	256	258	GAC	785	787	GAC	148;148;150	G;A;C	122;121;125	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1456	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3334	130.9	1	SNP	p	S87R	0	.	.	259	261	AGT	788	790	AGT	149;148;148	A,C;G;T,G	120,1;124;125,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1456	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3334	130.9	1	SNP	p	S87I	0	.	.	259	261	AGT	788	790	AGT	149;148;148	A,C;G;T,G	120,1;124;125,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1456	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3334	130.9	1	SNP	p	S87W	0	.	.	259	261	AGT	788	790	AGT	149;148;148	A,C;G;T,G	120,1;124;125,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1456	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3334	130.9	1	SNP	p	S88P	0	.	.	262	264	TCC	791	793	TCC	148;147;147	T;C;C	124;128;126	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	1276	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3112	122.9	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1776	1778	GGT	178;179;178	G;G;T	149;146;151	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1552	1554	GCA	175;176;176	G,T;C;A	148,2;151;155	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1555	1557	ATC	178;178;178	A;T;C	154;148;155	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1567	1569	GTG	172;172;174	G;T;G	153;154;154	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1567	1569	GTG	172;172;174	G;T;G	153;154;154	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2071	2073	ACC	140;141;141	A;C;C,A	118;119;122,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2125	2127	GCG	127;128;128	G;C,G;G	112;96,1;100	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2125	2127	GCG	127;128;128	G;C,G;G	112;96,1;100	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2248	2250	GGT	147;148;149	G,C;G,T;T	123,1;128,1;129	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2257	2259	GGC	148;148;147	G;G;C	131;131;122	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1166	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2975	117.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2275	2277	CCG	144;144;145	C;C;G	117;126;127	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1602	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3366	142.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	860	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2328	110.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	709	711	GGC	137;138;138	G,T;G,A;C	112,1;118,1;120	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	860	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2328	110.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	891	891	C	104	C	97	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	T18M	NONSYN	52	54	ACG	532	534	ATG	178;178;178	A;T;G,T	150;149;144,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	E48G	NONSYN	142	144	GAA	622	624	GGA	173;174;174	G;G;A	149;149;150	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	V75I	NONSYN	223	225	GTT	703	705	ATT	183;183;182	A;T,G;T	153;153,1;151	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	T89S	NONSYN	265	267	ACC	745	747	AGC	187;185;184	A,G;G;C	154,1;158;154	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	V98I	NONSYN	292	294	GTC	772	774	ATC	177;177;177	A;T,G;C	150;150,1;151	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	.	MULTIPLE	358	359	AA	837	838	CG	168;167	C;G,T	146;141,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	.	MULTIPLE	361	362	GA	840	842	CAG	165;166;166	C;A;G,T	141;139;139,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	N122K	NONSYN	364	366	AAC	844	846	AAA	164;165;164	A;A;A	139;142;138	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	871	873	TAT	161;160;160	T;A;T	135;136;129	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	N134K	NONSYN	400	402	AAT	880	882	AAG	153;153;153	A;A,G;G	132;133,1;132	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	V135F	NONSYN	403	405	GTG	883	885	TTT	153;155;154	T;T;T	126;131;129	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	G140K	NONSYN	418	420	GGA	898	900	AAA	159;159;159	A;A;A,G	135;136;138,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	K143E	NONSYN	427	429	AAA	907	909	GAA	162;160;163	G;A,G;A	139;135,1;136	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	931	933	GCA	168;170;171	G,T;C;A,C	145,1;143;142,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1117	1119	TCA	171;172;172	T,G;C;A	150,1;148;152	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1237	1239	CAA	173;173;173	C,A;A;A	153,1;156;155	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	.	INDELS	760	762	ACA	1241	1245	ATCAA	171;171;171;168;168	A;T;C;A;A	151;150;152;149;149	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	.	INDELS	763	764	TG	1248	1250	AGT	171;171;170	A;G,T;T	155;156,1;153	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1255	1257	GAT	171;171;171	G,T;A;T	149,2;154;152	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	T269S	NONSYN	805	807	ACC	1291	1293	AGC	175;176;177	A;G;C	152;151;153	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1363	1365	AGT	205;207;207	A,G;G,A;T,G	164,1;162,1;169,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1369	1371	GAC	204;204;204	G,A;A;C	162,2;168;163	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1372	1374	TAC	203;200;202	T,C;A;C	166,1;165;163	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	1	SNP	p	G120K	1	.	.	358	360	AAG	837	839	CGG	168;167;166	C;G,T;G,T	146;141,1;139,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	1	SNP	p	A121D	1	.	.	361	363	GAC	840	843	CGC	165;166;166	C;G,T;C	141;139,1;140	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	892	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	1948	134.7	1	SNP	p	D121N	0	.	.	361	363	GAC	840	843	CGC	165;166;166	C;G,T;C	141;139,1;140	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	3004	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5297	170.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2263	2265	CAT	153;152;152	C,A;A;T,G	130,1;129;126,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	478	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1429	99.9	1	SNP	p	V57M	1	.	.	169	171	ATG	648	650	ATG	176;176;176	A;T;G	151;154;152	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
